Question 1

What are the potential side effects of BGG492 compared to sumatriptan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of BGG492 in the Treatment of Migraine clinical trial (NCT00892203). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this trial compare to other treatment options I have for my migraines?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of BGG492 in the Treatment of Migraine clinical trial (NCT00892203). Contact the study team or your healthcare provider for specific answers.

Question 3

What would my participation in this trial involve in terms of visits and treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of BGG492 in the Treatment of Migraine clinical trial (NCT00892203). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific eligibility criteria I should be aware of before considering this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of BGG492 in the Treatment of Migraine clinical trial (NCT00892203). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress and response to the treatment be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of BGG492 in the Treatment of Migraine clinical trial (NCT00892203). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience a severe migraine during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of BGG492 in the Treatment of Migraine clinical trial (NCT00892203). Contact the study team or your healthcare provider for specific answers.

What this study is about